Investor desk
Investors should track partnership announcements and pipeline signals from Duke Industry Statistics.
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration projects addressing key methodological challenges in studies using real-world data (RWD). This webinar will highlight how the RCT-DUPLICATE initi
Presentation data updated Apr 18, 2026, 2:23 PM UTC
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration projects addressing key methodological challenges in studies using real-world data (RWD).
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration projects addressing key methodological challenges in studies using real-world data (RWD).
Expect signals on pricing, formulary strategy, and partnership economics in US markets.
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Investors should track partnership announcements and pipeline signals from Duke Industry Statistics.
Competitive positioning among general players is a core theme — compare with prior editions.
Tier-1 industry catalyst
Duke Industry Statistics is a targeted general forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
Some historical catalysts; compare readouts against last cycle.
Niche coverage — subscribe for direct abstract alerts.
Early science or services-focused — lower near-term PDUFA linkage.
Abstract discovery in progress; monitor Key Data tab.
Live readouts, late-breakers, and partnership announcements.
Nova editorial monitors confirmed data releases.
Post-event recap, competitive takeaways, and trial updates.
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration projects addressing key methodological challenges in studies using real-world data (RWD).
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Investors should track partnership announcements and pipeline signals from Duke Industry Statistics.
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Competitive positioning among general players is a core theme — compare with prior editions.
| Edition | Presentations | Companies |
|---|---|---|
| Duke Industry Statistics (current) | 0 | 0 |
| Duke Industry Statistics (2026) | 0 | 0 |
| Duke Industry Statistics (2026) | 0 | 0 |
Competitive positioning among general players is a core theme — compare with prior editions.
No coverage articles yet. Check back closer to the event.
Standalone summaries for Duke Industry Statistics — optimized for research and AI retrieval.
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration projects addressing key methodological challenges in studies using real-world data (RWD).
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration projects addressing key methodological challenges in studies using real-world data (RWD).
Investors should track partnership announcements and pipeline signals from Duke Industry Statistics.
BD teams should prioritize partnership and licensing conversations at Duke Industry Statistics.
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Duke Industry Statistics is a general industry conference for executives, clinical leaders, and investors.
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on general.
Duke Industry Statistics influences partnership timing and policy debates affecting general markets for the next 12–18 months.
Duke Industry Statistics is held in Cary, USA.
Track partnership announcements, pipeline readouts, and management commentary on general catalysts.
BD teams use Duke Industry Statistics for licensing, co-development, and vendor selection across general.
Duke Industry Statistics is a tier-1 global congress for general — compare with peer events in the same vertical.
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.